论文部分内容阅读
1985年内科住院冠心病患者96例,除常规治疗外,应用了硝苯吡啶。19例并有高血压的患者,用硝苯吡啶后血压有明显下降,对血压正常者则无明显影响。对急性心肌梗塞并有心衰者未发生低血压症。22例心绞痛患者,用药后20例得到完全控制,2例减轻,说明它是有效的抗心绞痛药。对心率无明显影响。不使心衰恶化。7例死亡病例,死因与硝苯吡啶无关。冠心病(包括心肌梗塞、心衰)合理应用硝苯吡啶是安全的。
In 1985, 96 patients with coronary heart disease were admitted to our hospital. In addition to routine treatment, nifedipine was used. 19 patients with hypertension and nifedipine blood pressure decreased significantly, no significant effect on normal blood pressure. Hypotension does not occur in patients with acute myocardial infarction and heart failure. Twenty-two patients with angina pectoris received complete control of 20 patients and 2 of them were relieved, indicating that it is an effective anti-anginal drug. No significant effect on heart rate. Not worsened heart failure. Seven deaths were reported and the cause of death was not related to nifedipine. Coronary heart disease (including myocardial infarction, heart failure) rational use of nifedipine is safe.